🔎 Trials Near Me

Home › Chronic Kidney Disease › Illinois

Chronic Kidney Disease clinical trials in Illinois

18 studies for Chronic Kidney Disease are looking for participants at sites in Illinois.

Cities in Illinois

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Champaign
  • Research Site, Maywood
  • Research Site, Rockford
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

  • Comprehensive Transplant Center, Chicago
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Sep 25, 2026 · NCT05106387

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  • Research Site, Oak Brook
  • Research Site, Rockford
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 24, 2026 · NCT07624305

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Accellacare - DuPage, Lombard
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 16, 2026 · NCT07107945

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Research by Design, LLC - Internal Medicine, Chicago
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 11, 2026 · NCT07271186

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, Champaign
  • Research Site, Chicago
  • Research Site, Chicago
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07753993

Breakthrough - T1DM and Chronic Kidney Disease

  • The University of Chicago, Chicago
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Aug 20, 2026 · NCT07592000

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingEarly phase 1
Ages 12 to 25 · All sexes · Updated Aug 19, 2026 · NCT06430684

Study of BHV-1400 in IgA Nephropathy

  • Site-009, Hinsdale
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

  • Northwestern Memorial Hospital, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT01644903

Empagliflozin Treatment in Kidney Transplant Recipients

  • Edward Hines Jr. VA Hospital, Hines, IL, Hines
RecruitingPhase 4
Ages 19 and older · All sexes · Updated Apr 21, 2026 · NCT06013865

Kidney Precision Medicine Project

  • University of Illinois Chicago, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT04334707

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

  • Northwestern Memorial Hospital, Chicago
RecruitingPhase 1/2
Ages 40 to 70 · All sexes · Updated Mar 27, 2026 · NCT06878560

Transformative Research in Diabetic Nephropathy

  • Northwestern University, Chicago
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Feb 27, 2026 · NCT02986984

Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy

  • University of Chicago Medical Center, Chicago
Recruiting
Ages 18 to 70 · All sexes · Updated Nov 14, 2025 · NCT06397456

Interactive Computer-adaptive Chronic Kidney Disease Education Program

  • University of Chicago Medical Center, Chicago
Recruiting
Ages 18 to 70 · All sexes · Updated Jan 8, 2025 · NCT06364358

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.